• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

TABLE 81Unit costs for tests and visits

TestCost (£)Source
FBC4.55Values from Chen 2006179 inflated to 2008 prices using the Hospital and Community Health Services inflation index (Curtis 2008)207
ESR3.51
BCP4.39
CXR17.82
Urinalysis0.09
Visit
GP36Curtis 2008207
Hospital outpatient71
Specialist nurse visit35.50Assumed half of outpatient visit
Administration of infusion141.83Chen 2006179 inflated to 2008 prices

BCP, biochemical profile; CXR, chest X-ray; FBC, full blood count.

From: 4, Assessment of cost-effectiveness

Cover of Adalimumab, Etanercept, Infliximab, Rituximab and Abatacept for the Treatment of Rheumatoid Arthritis After the Failure of a Tumour Necrosis Factor Inhibitor: A Systematic Review and Economic Evaluation
Adalimumab, Etanercept, Infliximab, Rituximab and Abatacept for the Treatment of Rheumatoid Arthritis After the Failure of a Tumour Necrosis Factor Inhibitor: A Systematic Review and Economic Evaluation.
Health Technology Assessment, No. 15.14.
Malottki K, Barton P, Tsourapas A, et al.
Southampton (UK): NIHR Journals Library; 2011 Mar.
© 2011, Crown Copyright.

Included under terms of UK Non-commercial Government License.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.